Print Page | Sign In
PCOM/Lehigh Valley Health Network
Share |

Speakers: Huyenlan Dinh, DO; Elise Grgurich, DO

Premalignant and Malignant Non-Melanoma Skin Cancer 


  1. Review basic knowledge regarding premalignant and malignant dermatologic lesions
  2. Discuss up-to-date literature on staging and managing high risk squamous cell carcinoma
  3. Evaluate new treatment modalities for premalignant and malignant lesions


  1. New advances in dermatologic treatment
  2. Availability of new medication(s) or indication(s)
  3. Advances in medical knowledge
  4. New methods of diagnosis or treatment


  • Cheng J, Yan S. Prognostic Variables in High-Risk Cutaneous Squamous Cell Carcinoma: A Review. Journal of Cutaneous Pathology. Apr 2016.
  • Scarisbrick JJ, Prince HM, Vermeer MH, et al. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J Clin Oncol. 2015 Nov 10; 33(32): 3766–3773.

Core Competencies: 1, 2, 3, 6, 7

Disclosures: No disclosures provided by speakers

2902 North Baltimore Street | P.O. Box 7525 | Kirksville, Missouri 63501

660-665-2184 | 1-800-449-2623 | 660-627-2623